Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer

BACKGROUND: Phenoxodiol is a novel isoflavone currently being studied in clinical trials for the treatment of cancer. This study reports the pharmacokinetics of phenoxodiol in patients with cancer. METHODS: The pharmacokinetics of phenoxodiol was studied following a single intravenous (iv) bolus dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Howes, Jan B, de Souza, Paul L, West, Leanne, Huang, Li Jiu, Howes, Laurence G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045896/
https://www.ncbi.nlm.nih.gov/pubmed/21291562
http://dx.doi.org/10.1186/1472-6904-11-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045896/
https://www.ncbi.nlm.nih.gov/pubmed/21291562
http://dx.doi.org/10.1186/1472-6904-11-1

Ejemplares similares